Why Moderna's Latest Supply Deal Could Make the Stock a Big Bargain Right Now

Moderna (NASDAQ: MRNA) isn't exactly what most investors would think of as a cheap stock. Its shares are trading near all-time highs. The company's market cap of well over $70 billion might seem too high to many.

However, last week Moderna announced a supply agreement with Israel for its COVID-19 vaccine that could be a predictive indicator for investors to take note of. It's even possible that this latest supply deal could mean that the stock is a pretty big bargain right now. Here's why.

Image source: Getty Images.

Source Fool.com